FDA gives thumbs up to Synergy for HBR indication Aug. 12, 2020 By Liz Hollis No Comments Boston Scientific Corp. has received the U.S. FDA’s nod for a high bleeding risk (HBR) indication for the Synergy drug-eluting stent system.Read More